Reem N. El‐Naga

967 total citations
32 papers, 792 citations indexed

About

Reem N. El‐Naga is a scholar working on Molecular Biology, Biological Psychiatry and Pathology and Forensic Medicine. According to data from OpenAlex, Reem N. El‐Naga has authored 32 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Biological Psychiatry and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Reem N. El‐Naga's work include Tryptophan and brain disorders (7 papers), Cancer-related cognitive impairment studies (5 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). Reem N. El‐Naga is often cited by papers focused on Tryptophan and brain disorders (7 papers), Cancer-related cognitive impairment studies (5 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). Reem N. El‐Naga collaborates with scholars based in Egypt and Indonesia. Reem N. El‐Naga's co-authors include Ebtehal El‐Demerdash, Noha M. Saeed, Eman Al‐Sayed, Ekram Nemr Abd Al Haleem, Hebatalla I. Ahmed, Ebtehal El‐Demerdash, Wesam M. El‐Bakly, Amany M. Gad, Yasmen F. Mahran and Sara A. Wahdan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Reem N. El‐Naga

31 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reem N. El‐Naga Egypt 18 251 187 103 89 77 32 792
Azza S. Awad Egypt 17 199 0.8× 154 0.8× 132 1.3× 92 1.0× 52 0.7× 42 818
Rehab Ahmed Rifaai Egypt 17 268 1.1× 144 0.8× 98 1.0× 74 0.8× 81 1.1× 48 909
Basim Anwar Shehata Messiha Egypt 21 251 1.0× 97 0.5× 128 1.2× 96 1.1× 103 1.3× 50 953
Abdulaziz A. Al‐Yahya Saudi Arabia 16 246 1.0× 248 1.3× 103 1.0× 48 0.5× 81 1.1× 24 903
Mohamed A. El‐Moselhy Egypt 19 294 1.2× 103 0.6× 116 1.1× 70 0.8× 137 1.8× 39 975
Shohda A. El‐Maraghy Egypt 20 421 1.7× 112 0.6× 89 0.9× 83 0.9× 59 0.8× 40 1.1k
Mamdouh M. El‐Shishtawy Egypt 20 391 1.6× 73 0.4× 145 1.4× 133 1.5× 47 0.6× 49 1.1k
Dina F. Mansour Egypt 16 169 0.7× 112 0.6× 113 1.1× 64 0.7× 28 0.4× 28 579
Marawan A. Elbaset Egypt 18 220 0.9× 56 0.3× 106 1.0× 142 1.6× 59 0.8× 70 803
Víctor García United States 20 492 2.0× 145 0.8× 117 1.1× 96 1.1× 231 3.0× 41 1.4k

Countries citing papers authored by Reem N. El‐Naga

Since Specialization
Citations

This map shows the geographic impact of Reem N. El‐Naga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reem N. El‐Naga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reem N. El‐Naga more than expected).

Fields of papers citing papers by Reem N. El‐Naga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reem N. El‐Naga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reem N. El‐Naga. The network helps show where Reem N. El‐Naga may publish in the future.

Co-authorship network of co-authors of Reem N. El‐Naga

This figure shows the co-authorship network connecting the top 25 collaborators of Reem N. El‐Naga. A scholar is included among the top collaborators of Reem N. El‐Naga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reem N. El‐Naga. Reem N. El‐Naga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
7.
Wahdan, Sara A., et al.. (2021). Saxagliptin ameliorated the depressive-like behavior induced by chronic unpredictable mild stress in rats: Impact on incretins and AKT/PI3K pathway. European Journal of Pharmacology. 912. 174602–174602. 16 indexed citations
8.
Saeed, Noha M., et al.. (2021). The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways. Toxicology Letters. 347. 23–35. 26 indexed citations
9.
Tolba, Mai F., et al.. (2021). Rosuvastatin and low‐dose carvedilol combination protects against isoprenaline‐induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO‐1 signalling. Clinical and Experimental Pharmacology and Physiology. 48(10). 1358–1370. 9 indexed citations
10.
El‐Naga, Reem N., et al.. (2021). Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway. Toxicology and Applied Pharmacology. 435. 115853–115853. 32 indexed citations
11.
El‐Naga, Reem N., et al.. (2020). Dibenzazepine Attenuates Against Cisplatin-Induced Nephrotoxicity in Rats: Involvement of NOTCH Pathway. Frontiers in Pharmacology. 11. 567852–567852. 18 indexed citations
12.
El‐Naga, Reem N., et al.. (2019). Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway. Chemico-Biological Interactions. 308. 137–146. 42 indexed citations
13.
El‐Naga, Reem N., et al.. (2016). Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride‐induced liver fibrosis in rats. British Journal of Pharmacology. 173(22). 3248–3260. 62 indexed citations
14.
El‐Naga, Reem N. & Yasmen F. Mahran. (2016). Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1. Scientific Reports. 6(1). 29857–29857. 31 indexed citations
15.
Saeed, Noha M., et al.. (2015). Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study. Biochemical Pharmacology. 95(3). 145–155. 92 indexed citations
16.
Darwish, Samar F., Wesam M. El‐Bakly, Reem N. El‐Naga, Azza S. Awad, & Ebtehal El‐Demerdash. (2015). Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: Impact on interferon therapy. Biochemical Pharmacology. 98(1). 231–242. 29 indexed citations
17.
El‐Naga, Reem N.. (2015). Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4. Chemico-Biological Interactions. 242. 317–326. 26 indexed citations
18.
Mahran, Yasmen F., Ebtehal El‐Demerdash, Ahmed S. Nada, et al.. (2015). Growth Hormone Ameliorates the Radiotherapy-Induced Ovarian Follicular Loss in Rats: Impact on Oxidative Stress, Apoptosis and IGF-1/IGF-1R Axis. PLoS ONE. 10(10). e0140055–e0140055. 18 indexed citations
20.
El‐Naga, Reem N., Hebatalla I. Ahmed, & Ekram Nemr Abd Al Haleem. (2014). Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine levels. NeuroToxicology. 44. 48–57. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026